Home Pharma China Web Edition Pharma China Archives Online Databases Subscription/Order/Info Event Calendar China Pharma Providers About Us
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Featured News
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor´s Picks
 
 
 
China's Evolving Pharma Partnering Landscape: The Right Partner Profile
Identifying the need for a partner in the China pharmaceutical market is a critical strategic decision, but more critical is the selection of a partner that can best alig... (12/12/2014)
   
China's Health Food Reforms Offer More Proposals than Solutions (12/15/2014)
China's Evolving Pharma Partnering Landscape: The Right Partner Profile (12/12/2014)
Foreign Drug Companies in China See Approval Delays (External) (12/8/2014)
Top 5 MCM Trends in China, Emerging Markets and Japan (12/2/2014)
China Daily: Drug Firms Seek New Strategies (External) (11/30/2014)
China Issues Draft Guidance On Multi-Regional Clinical Trials (11/27/2014)
NDRC's Ill-fated Drug Price Reform Path and Latest Proposal to Exit (11/27/2014)
American Biotech Start-Ups Head To China For Capital Partners (External) (11/25/2014)
Chinese Pharma to Grow Slower Amid Uncertainties and Proposed Liberalizations (11/24/2014)
China Telemedicine: How it Might Reshape Pharmacies (11/23/2014)
An Unexpected Reality in the Post-GSK World (11/20/2014)
China Healthcare Multi Channel Marketing? OK, But Where? (11/19/2014)
China Healthcare Advertising: Failure to Learn (11/19/2014)
Review of Chinese Pharma Deals, R&D and Regulatory Developments in Q3/2014 (11/14/2014)
China Solicits Comments On Biosimilars Guideline (11/6/2014)
CFDA Issues Draft of "Provision...  (12/17/2014)
Pioneer Pharma to Offer NovaBay's Neutro...  (12/17/2014)
Two Medical Reps Handed Jail Sentences w...  (12/17/2014)
Chinese Animal Vaccine Market Expect to ...  (12/16/2014)
Data Snapshot - Chinese Registration Tim...  (12/16/2014)
Zhejiang Selects 31 Expensive Drugs for ...  (12/15/2014)
WuXi PharmaTech to Open Offices in Bosto...  (12/15/2014) (free)
Data Snapshot - Hospital Drug Consumptio...  (12/15/2014)
Data Snapshot - 2014 Ranking of Chinese ...  (12/15/2014) (free)
Financial-related Company News in Brief  (12/15/2014)
Luqa Licenses China Rights of Woundcare ...  (12/15/2014)
Suven Gets Another Chinese Patent for It...  (12/12/2014)
GlobalData: Pharma Cos to Lose $65B by 2...  (12/12/2014)
Recent Executive Moves  (12/12/2014)
Shanghai Liberalizes Drug Prices Ahead o...  (12/12/2014)
GlobalData: Pharma Cos to Lose $65B by 2019 Due To Paten...
Deloitte: Returns on Pharma R&D Improving as Pipelin...
Improving Access to Medicine in Developing Countries
2014 The Most Active Year for Healthcare Deals in Two De...
CSDD: Cost to Develop A New Drug Now Exceeds US$2.5B
Chinese Animal Vaccine Market Expect to Rise 15% Annually Befor...
Data Snapshot - Hospital Drug Consumption and TC Structural Cha...
Nicholas Hall Reports Latest Data on Chinese OTC Eye Care and S...
Expanding Chinese Type 2 Diabetes Population Has Impeded Access...
Data Snapshot - Hospital Consumption of Anti-cholesterol Drugs ...
CFDA Issues Draft of "Provisions for Food and Drug ...
Pioneer Pharma to Offer NovaBay's NeutroPhase Free to Patien...
WuXi PharmaTech to Open Offices in Boston and San Francisco
Data Snapshot - 2014 Ranking of Chinese Pharma Chemicals Com...
Financial-related Company News in Brief
Data Snapshot - Chinese Registration Timeframe for Class...
CFDA Issues Notice Over Technology Transfer of Sterile D...
CFDA VM meets the Czech State Institute for Drug Control...
CFDA Issues Warning Letters to Certain Pharmaceutical Ma...
CDE, PKU No.1 Hospital Enter Partnership for Talent Buil...
Two Medical Reps Handed Jail Sentences with Probation in Sha...
Fujifim to Sue Sihuan Pharma over IP Infringements Related t...
Baker McKenzie: China Ramps Up Antimonopoly Law with Focus o...
Bayer Settles Six-Year Trademark Infringement Lawsuit with H...
Thomson Reuters: China's Patent Dominance Despite Stagnant F...
Lonza to Manufacture Sunshine Biopharma's Novel Anticanc...
Baiyunshan, Alkpharm to Join Hands for API Manufacturing...
UniTao Pharma Buys Boehringer Ingelheim's API Facility i...
India Depends On China for 90% of Its Key APIs and Inter...
Chinese Heparin API Market to Account Roughly 80% of Glo...
Suven Gets Another Chinese Patent for Its NECs for Neuro...
BeyondSpring Pharma to Initiate Phase 3 Trials for Its N...
China Inaugurates National Center for Translational Medi...
SIMM Scientists Discover Novel Anti-coagulant Drug Candi...
SIMM Develops Novel Drug Candidate for B Cell Acute Lymp...
Zhejiang Selects 31 Expensive Drugs for Negotiated BMI C...
NHFPC to Establish National Drug Price Negotiation Commi...
WHO Warns China Over Rising HIV/AIDS
2014 China Mobile Health Report Finds Positive Growth Pr...
Alzheimer's Disease and Dementia Keep Rising in China As...
Recent Executive Moves
Recent Executive Moves
Recent Executive Moves
Recent Executive Moves
Recent Executive Moves
Upcoming Event: Asia Vaccine Development Leaders Summit ...
Upcoming Event: BioPharma Asia Convention 2015
Upcoming Event: Biotech China 2015
Upcoming Event: Annual Biologics World Taiwan 2015
Upcoming Event: Executive Etiquette Excellence Seminar b...
Pharma China is the most influential English media and source of business intelligence covering the Chinese pharmaceutical and biopharmaceutical sector...
WiCON has been helping international healthcare companies succeed in China and other Asian markets since 1991. We advise our clients on every stage of their China and Asian business. We worked with clients in many regions of the world...
  WiCON Officially Publishes Chi...
  WiCON Officially Publishes Its...
  WiCON Publishes China Pharmace...
  WiCON officially publishes Chi...
  Pharma China adds one more dis...
© Wicon International Group  Support by: www.heightow.com Site map | Contact Us | Links